NAUT

0.9896

11.64% -0.1304

Dopo l'orario di chiusura: .98 -0.0096 -0.97%

Nautilus Biotechnology Inc (NAUT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.12

Aprire:

$1.12

Volume 24 ore:

1.96M

Relative Volume:

2.08

Capitalizzazione di mercato:

$125.93M

Reddito:

Utile/perdita netta:

$-57.09M

Rapporto P/E:

-2.1908

EPS:

-0.4517

Flusso di cassa netto:

$-51.43M

1 W Prestazione:

+7.62%

1M Prestazione:

+14.40%

6M Prestazione:

-59.28%

1 anno Prestazione:

+39.97%

Intervallo 1D:

$0.9727

$1.1273

Intervallo di 1 settimana:

$0.89

$1.14

Portata 52W:

$0.681

$4.3101

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Nome

Nautilus Biotechnology Inc

Settore

Healthcare (1069)

Industria

Biotechnology (595)

Telefono

206-333-2001

Indirizzo

2701 EASTLAKE AVE EAST, SEATTLE

Dipendente

130

Cinguettio

Prossima data di guadagno

2026-10-26

Ultimi documenti SEC

NAUT's Discussions on Twitter

Compare NAUT vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
NAUT Nautilus Biotechnology Inc	0.9896	142.53M	0	-57.09M	-51.43M	-0.4517
VRTX Vertex Pharmaceuticals Inc	514.56	132.08B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.26	83.15B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.04	62.71B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	136.62	54.14B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.35	44.51B	742.00K	-1.37B	-1.07B	-7.0731

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-05	Downgrade	Goldman	Neutral → Sell
2024-06-27	Iniziato	Guggenheim	Buy
2024-06-03	Ripresa	Jefferies	Hold
2022-01-06	Iniziato	Morgan Stanley	Equal-Weight
2021-11-02	Iniziato	Cowen	Outperform
2021-08-04	Iniziato	Goldman	Neutral
2021-07-13	Iniziato	Jefferies	Buy

Mostra tutto

Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie

Sep 04, 2026

Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms - Investing News Network

Sep 04, 2026

Nautilus Biotechnology paper on tau proteoform analysis published in Nature Methods - Traders Union

Sep 04, 2026

Nautilus found 130 forms of a protein linked to Alzheimer’s. Some appeared in just 0.1% of samples. - Stock Titan

Sep 04, 2026

Sep 02, 2026

Nautilus Biotechnology (NAUT) Advances 3.81% to $0.96, Testing Move Toward Key $1.01 ResistanceWyckoff Accumulation - dars.gov.et

Sep 02, 2026

Nautilus Biotechnology heads to HUPO 2026 to unveil Voyager platform breakthroughs - Traders Union

Sep 02, 2026

Aug 28, 2026

Andreessen Horowitz sells Nautilus (NAUT) shares around $1 - Stock Titan

Aug 28, 2026

Aug 24, 2026

Nautilus (NAUT) Market: Finishes 8.30% Down at $0.88 in the Latest Session; Price Levels: the Session Ends Within the Reported Technical BoundariesValue Area Low - vinanet.vn

Aug 24, 2026

Nautilus (NAUT) Financial Results: Profit Per Share Surpasses Its Benchmark in the Current Update; Trading Move - vinanet.vn

Aug 24, 2026

Aug 21, 2026

Nautilus Biotechnology urges new methods to address biological validation challenge in proteomics - Traders Union

Aug 21, 2026

Aug 19, 2026

Nautilus (NAUT) Watch: Closes 5.82% Higher at $0.90; Technical View: Traders Can Monitor the $0.85-$0.95 Range for the Current SessionSystematic Flow - vinanet.vn

Aug 19, 2026

Aug 18, 2026

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest - MarketBeat

Aug 18, 2026

Aug 14, 2026

Nautilus Biotechnology Earnings Call Balances Promise and Risk - TipRanks

Aug 14, 2026

NAUT Q2 2026 Earnings: Narrower Loss Surprise Lifts Shares 22%Earnings Deceleration Risk - vinanet.vn

Aug 14, 2026

Perceptive Advisors group reports 9.1% Nautilus (NAUT) ownership in updated 13D/A - Stock Titan

Aug 14, 2026

Aug 11, 2026

Nautilus Biotechnology (NAUT) Slides 3.9% to $0.86, Approaching Key Support LevelLiquidity Order Flow - vinanet.vn

Aug 11, 2026

Aug 10, 2026

Nautilus Biotechnology (NAUT) Steadies Near $0.89 as Support HoldsUpthrust Pattern - vinanet.vn

Aug 10, 2026

Aug 07, 2026

Nautilus Biotechnology Inc (NASDAQ: NAUT) Share Price, NAUT Stock News, NAUT Share Price & Updates - Kalkine

Aug 07, 2026

Nautilus Biotechnology (NAUT) Institutional Ownership 2026 - MarketBeat

Aug 07, 2026

Aug 06, 2026

Nautilus Biotechnology unveils new proteomics approach for dementia studies - Traders Union

Aug 06, 2026

Aug 03, 2026

Nautilus Biotechnology: A Contrarian Proteoformics Play After Recent Pullback (NAUT) - Seeking Alpha

Aug 03, 2026

Jul 31, 2026

Nautilus Biotechnology, Inc. Revenue Breakdown – NASDAQ:NAUT - TradingView

Jul 31, 2026

Jul 30, 2026

Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Rises By 74.6% - MarketBeat

Jul 30, 2026

Jul 29, 2026

Nautilus Biotechnology sets 31 July deadline for Iterative Mapping Grant Program applications - tradersunion.com

Jul 29, 2026

Jul 28, 2026